Enliven Therapeutics Email Format

Biotechnology ResearchColorado, United States51-200 Employees

Enliven Therapeutics is a clinical-stage biotechnology company based in Boulder, Colorado, focused on discovering and developing small molecule therapeutics intended to extend life and enhance its quality. The company uses a precision medicine framework to address unmet medical needs, aiming to deliver therapies that may be first-in-class or best-in-class. Its discovery approach blends insights from clinically validated biological targets with differentiated chemistry to shape candidate compounds. Its therapeutic focus centers on oncology, specifically the development of next-generation small molecule kinase inhibitors. As a midsize biotechnology firm, Enliven engages with the broader biotech community and periodically participates in investor and scientific conferences, such as presenting at the TD Cowen Health Care Conference in 2026.

Sign up for free to view info

Company overview Employee directory